Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment

Acta Ophthalmologica

Volumn 89, Issue 4, 2011, Pages 339-345

  Symeonidis, Chrysanthos ^a   Papakonstantinou, Eleni ^a   Souliou, Efimia ^a   Karakiulakis, George ^a   Dimitrakos, Stavros A ^a   Diza, Eudoxia ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

matrix metalloproteinases; proliferative vitreoretinopathy; rhegmatogenous retinal detachment; subretinal fluid; vitreous fluid

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DETACHMENT; SCLERA BUCKLING PROCEDURE; SUBRETINAL FLUID; VITRECTOMY; VITREORETINOPATHY; ZYMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; RETINAL DETACHMENT; SCLERAL BUCKLING; SUBRETINAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY; YOUNG ADULT;

EID: 79958085982     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01701.x     Document Type: Article

References (34)

1. Abouzeid H, Becker K, Holz FG, &, Wolfensberger TJ, (2009): Submacular fluid after encircling buckle surgery for inferior macula-off retinal detachment in young patients. Acta Ophthalmol 87: 96-99.
2. Abu El-Asrar AM, Dralands L, Veckeneer M, Geboes K, Missotten L, Van Aelst I, &, Opdenakker G, (1998): Gelatinase B in proliferative vitreoretinal disorders. Am J Ophthalmol 125: 844-851. (Pubitemid 28283745)
3. Aylward GW, (2004): Proliferative vitreoretinopathy. In:, Yanoff D, &, Duker JS, (eds) Ophthalmology. St Louis: Mosby, 1002-1006.
4. Bachmeier BE, Nerlich AG, Boukamp P, Lichtinghagen R, Tschesche H, Fritz H, &, Fink E, (2000): Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases -1, -8 and -13 and of TIMP-1. Biol Chem 381: 509-516. (Pubitemid 30453829)
5. Behzadian MA, Wang XL, Windsor LJ, Ghaly N, &, Caldwell RB, (2001): TGF-U increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial cells in endothelial barrier function. Invest Ophthalmol Vis Sci 42: 853-859. (Pubitemid 32206931)
6. Borden P, &, Heller RA, (1997): Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 7: 159-178. (Pubitemid 27148904)
7. Cao J, Sato H, Takino T, &, Seiki M, (1995): The C-terminal region of membrane type matrix metalloproteinase is a functional trans-membrane domain required for progelatinase A activation. J Biol Chem 270: 801-805.
8. Casaroli R, &, Vilarõ S, (1994): The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 35: 2791-2803. (Pubitemid 24149792)
9. Eichler W, Friedrichs U, Thies A, Tratz C, &, Wiedemann P, (2002): Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. Invest Ophthalmol Vis Sci 43: 2767-2773. (Pubitemid 34809471)
10. Gonzalez-Avila G, Mendez D, Lozano D, Ramos C, Delgado J, &, Iturria C, (2004): Role of retinal detachment subretinal fluid on extracellular matrix metabolism. Ophthalmologica 218: 49-56. (Pubitemid 38037058)
11. Hiscott P, Sheridan C, Magee RM, &, Grierson I, (1999): Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res 18: 167-190. (Pubitemid 29023054)
12. Jerdan JA, Pepose JS, Michels RG, Hayashi H, de Bustros S, Sebag M, &, Glaser BM, (1989): Proliferative vitreoretinopathy membranes: an immunohistochemical study. Ophthalmology 96: 801-810. (Pubitemid 19165107)
13. Karakiulakis G, Papanikolaou C, Jankovic SM, Aletras A, Papakonstantinou E, Vretou E, &, Mirtsou-Fidani V, (1997): Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. Invasion Metastasis 17: 158-168. (Pubitemid 28379689)
14. Kirchhof B, (2004): Strategies to influence PVR development. Graefes Arch Clin Exp Ophthalmol 242: 699-703. (Pubitemid 39242847)
15. Kon CH, Occleston NL, Charteris D, Daniels J, Aylward GW, &, Khaw PT, (1998): A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 39: 1524-1529. (Pubitemid 28307381)
16. Papakonstantinou E, Dionyssopoulos A, Aletras AJ, Pesintzaki C, Minas A, &, Karakiulakis G, (2004): Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis. J Am Acad Dermatol 51: 526-533. (Pubitemid 39278070)
17. Parshley DE, Bradley JMB, Samples JR, Van Buskirk EM, &, Acott TS, (1995): Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork. Curr Eye Res 14: 537-544.
18. Pastor JC, de la Rua ER, &, Martin F, (2002): Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 21: 127-144. (Pubitemid 34242710)
19. Pauschinger M, Chandrasekharan K, &, Schultheiss HP, (2004): Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system. Heart Fail Rev 9: 21-31. (Pubitemid 38196074)
20. Plantner JJ, Jiang C, &, Smine A, (1998): Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 67: 637-645. (Pubitemid 29052401)
21. Retina Society Terminology Committee (1983): The classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 90: 121-125.
22. Salzmann J, Limb GA, Khaw PT, Gregor ZJ, Webster L, Chignell AH, &, Charteris DG, (2000): Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 84: 1091-1096.
23. Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, &, Charteris DG, (2005): Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 46: 329-342. (Pubitemid 40041216)
24. Sheridan CM, Occleston NL, Hiscott P, Kon CH, Khaw PT, &, Grierson I, (2001): Matrix metalloproteinases: a role in the contraction of vitreo-retinal scar tissue. Am J Pathol 159: 1555-1566. (Pubitemid 32947983)
25. Sivak JM, &, Fini E, (2002): MMPs in the eye: emerging roles for matrix metalloproteinases in ocular pathology. Prog Retin Eye Res 21: 1-14. (Pubitemid 34242704)
26. Skiles JW, Gonella NC, &, Jeng AY, (2001): The design, structure and therapeutic application of matrix metalloproteinase inhibitors. Curr Med Chem 8: 425-474. (Pubitemid 32409788)
27. Stetler-Stevenson WG, Aznavoorian S, &, Liotta LA, (1993): Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573.
28. Symeonidis C, Diza E, Papakonstantinou E, Souliou E, Dimitrakos SA, &, Karakiulakis G, (2007a): Correlation of the extent and duration of rhegmatogenous retinal detachment with the expression of matrix metalloproteinases in the vitreous. Retina 27: 1279-1285. (Pubitemid 350211538)
29. Symeonidis C, Diza E, Papakonstantinou E, Souliou E, Karakiulakis G, &, Dimitrakos SA, (2007b): Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 245: 560-568. (Pubitemid 46477317)
30. Webster L, Chignell AH, &, Limb GA, (1999): Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy. Exp Eye Res 68: 91-98. (Pubitemid 29084577)
31. Wilkinson CP, (2004): Rhegmatogenous retinal detachment. In:, Yanoff D, &, Duker JS, (eds) Ophthalmology. St Louis: Mosby, 982-989.
32. Yeung L, Yang KJ, Chen TL, Wang NK, Chen YP, Ku WC, &, Lai CC, (2008): Association between severity of vitreous haemorrhage and visual outcome in primary rhegmatogenous retinal detachment. Acta Ophthalmol 86: 165-169.
33. Yong VW, Agrawal SM, &, Stirling DP, (2007): Targeting MMPs in acute and chronic neurological conditions. Neurotherapeutics 4: 580-589. (Pubitemid 47499287)
34. Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, &, Inomata H, (2002): Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-perfusion injury in rats. Exp Eye Res 74: 577-584. (Pubitemid 34757013)